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Wound dressingIn recent decades, wound dressings have evolved from the simple gauze to sophisticated, carefully designed
functional materials which can enhance wound healing and eliminate bacterial infections endangering the
wounded area. With an increasing number of multidrug-resistant strains, bacterial overgrowth of the injured
area poses a serious risk that can lead to severe conditions. Nanoparticles can exhibit remarkable antibacterial
properties thus incorporating them into biocompatible matrices, effective antibacterial wound dressings can be
fabricated. Utilizing electrospinning, nanoparticles could be easily incorporated into fibrous polymer meshes.
Next to nanoparticles, electrospinning allows the simultaneous encapsulation of small molecules as well,
resulting in complex nanocomposite meshes exhibiting antibacterial and anti-inflammatory and/or analgesic
properties. In the manuscript, we present a one-pot method for the synthesis of silver nanoparticles (AgNP) in
the presence of polysuccinimide (PSI) and a small molecule drug (paracetamol), followed by the fabrication of
an antibacterial wounddressing system. Thorough characterization of both theAgNP-containing colloidal system
and the meshes were performed. Results reveal the stabilizing effect of PSI and paracetamol enhancing the for-
mation of a monodisperse colloidal system. Mechanical studies confirm the reinforcing effect of silver-
nanoparticles, and antibacterial evaluation proves the applicability of the meshes. Drug-release measurement
shows prolonged three-step release kinetics.
© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Wound healing is defined as the process where damaged or lost tis-
sues are either regenerated or replaced. This process involves a complex
sequence of events and mechanisms composed of neural feedbacks,
chemical, andmolecular interactions as well as cellularmovement, pro-
liferation, and differentiation. Aberrations in wound healing, result due
to either local (e.g. moisture, oedema, infection) or generalized (e.g. di-
abetes, smoking, immunosuppression) conditions [1]. These factors can
delay or entirely prevent proper wound healing consequently resulting
in chronic conditions. In order to prevent the negative effect of these
factors and enhance the healing process, medical and scientific research
has been increasingly focusing on the functionalization and optimiza-
tion of wound dressings [2–4].
Wound dressings have evolved to sophisticatedmaterials with intri-
cate structures and specialized components, designed specifically to en-
hance and promote faster wound healing rates. While simple gauze
dressings are still widely used,wounddressings are nownot exclusively
composed of textiles. The research focus is now turning to advancedpest, Hungary.
hu (A. Jedlovszky-Hajdu).
. This is an open access article undermaterials, for example, films, hydrogels, foams, and nanofibers with an
emphasized objective on the prevention of bacterial infection, since
such an event can seriously delay the healing process and poses as a
major risk towards severe clinical conditions [3–7]. Each with its own
advantages and disadvantages, these modern materials are employed
as they are structurally designed to support the healing, absorb excess
wound exudate while preventing dehydration of the wounded area
and they can be combined with pharmaceutical agents providing anal-
gesia, and most importantly antibacterial agents preventing infections
[5,8,9].
While typically bacterial flora found on the skin poses no risk to a
patient, as the balance of the skin is disrupted due to chronic wounds
or immunocompromised conditions, even representatives of normal
bacterial flora can lead to pathological conditions [5]. Staphylococcus
epidermidis is part of healthy skin microbiota but is also known as
one of the leading causes of nosocomial infections and is rather hard
to eradicate with conventional antibiotics due to its biofilm-forming
characteristics [10–12]. Another bacterial strain typically acquired as
a nosocomial infection, Pseudomonas aeruginosa plays a crucial part
in impaired wound healing and exhibits extraordinary resistance to-
wards a wide range of antibiotics [13]. To overcome the widespread
antibiotic resistance of various pathogens, several strategies havethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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tibacterial polymers, essential oils, and other natural antibiotics such
as honey, antimicrobial peptides, phage therapy, and nanoparticles
[5,13,14]. Nanoparticles (NPs) are particularly effective against bacte-
rial infections, and they seem to be a promising candidate to replace
antibiotics against multidrug-resistant strains. According to various
studies, three mechanisms are proposed for the antibacterial action
of NPs: a. release of metal ions b. oxidative stress c. non-oxidative
mechanisms. Due to these three modes of action, NPs can effectively
penetrate the bacterial membrane, disrupt biofilm formation, gener-
ate reactive oxygen species, or even destabilize ribosomes [12,13,15].
One popular compound investigated regarding wound dressing ap-
plications is silver, as it exhibits exceptional antibacterial properties. In
particular silver nanoparticles (AgNP) have been investigated and
their positive results have been demonstrated several times yet, some
controversy still surrounds the subject [16]. While overall effective,
modifications to augment their effect are still possible. Theirmechanism
of action involves damaging the bacterial cell membrane as well as the
bacterial DNA [17]. Recently the correlation between the nanoparticle
size and surface area/volume ratio to antibacterial effect has been exam-
ined. AgNP distribution and size directly affect the total “antibacterial
surface” and thus the overall silver ion release and antibacterial efficacy.
For a wound dressing material to be a proper template for silver nano-
particles an essential prerequisite is to facilitate the silver ion release.
In this regard, nanofibers – possessing a high specific surface area- can
provide an excellent carrier for silver nanoparticles.
Nanofibers have been widely utilized in regenerative medicine and
tissue engineering as they possess several advantageous features
[18,19]. Undeniably, besides their chemical compositions, a wound
dressing's physical structure can greatly impact thewound healing pro-
cess. Nanofibers have a microstructure resembling the extracellular
matrix innately found around almost every cell in the human body.
Nanofibrous meshes are typically composed of either naturally
occurring (e.g. chitosan, alginic acid, hyaluronic acid) or synthetic
(poly (ε-caprolactone), poly(lactic acid), poly(vinyl alcohol)) polymers
[20–22]. Even without antibacterial properties nanofibrous meshes
have some interesting properties that can be useful for wound care
such as absorbing wound exudate, the release of analgesic pharmaceu-
tical compounds, promoting haemostasis phase due to their high sur-
face area and also their structure leads to semi-permeability which
facilitates the respiration of the cells [23]. However, since bacterial in-
fection is one of the leading causes of impaired wound healing, without
antibacterial efficacy nanofibrous meshes couldn't eliminate the risk of
such an infection and their use in woundcare is rather limited.
Nanofibrous meshes containing silver nanoparticles have been pre-
viously investigated yet, to our knowledge AgNPs have not been com-
bined with poly(succinimide) (PSI) based nanofibrous systems.
Poly(succinimide) is a polymer produced by the thermal polycon-
densation of L-Aspartic acid. It is a water-insoluble polymer that hy-
drolyses in even mild alkaline environment, such as physiological
pH. Additionally, PSI is easily modified as it is prone to react with nu-
cleophiles under mild conditions, resulting in water-soluble poly
(aspartic acid) (PASP) and its derivatives. These features coupled
with its biocompatible and biodegradable nature, make it a promising
polymer for tissue engineering, cell cultivation, and other biotechno-
logical applications. Utilizing PSI, hydrogels, nanogels, films, fibrous
hydrogels, and also non-woven fibrous meshes can be prepared
[24–27].
Electrospinning is one of several methods (e.g. wet-spinning, dry-
spinning, etc.) that is currently used to produce non-woven nanofibrous
membranes. Using a high voltage, provided by a power supply, nanofi-
bers can be fabricated from polymer solutions as they are pushed
through a needle. This method is quite prevalent as it is straightforward
but also provides numerous possibilities for modification and adjust-
ments making it probably the most versatile and cost-effective out of
all the spinning methods [28–30].2
In this manuscript, we are demonstrating how AgNPs as well as
pharmaceutical agents can be electrospun after a one-pot synthesis
method. The pharmaceutical agent of choice was paracetamol (APAP),
perhaps the most frequently used Non-Steroidal Anti-Inflammatory
Drug (NSAID). Our aim, by pairing paracetamol with AgNPs is to assess
the effect of a small-molecular drug on AgNP and how it could poten-
tially enhance or decrease the antibacterial effect of PSI based mem-
branes. Furthermore, PSI being a highly biocompatible polymer the
objective is to produce a functionalized biocompatible and biodegrad-
able wound dressing.
In the followingmanuscript,we present the synthesis and character-
ization of AgNPs and the fabrication and characterization of AgNP and
paracetamol containing PSI electrospun meshes. Silver nanoparticles
are known to be effective against biofilm-forming and multidrug-
resistant bacteria strains, therefore they are an excellent component
to incorporate inmodern functional wound dressings. Since the proper-
ties of these aforementioned particles depend on their colloidal proper-
ties, our aim was to develop an efficient one-pot method for the
synthesis of silver nanoparticles with tuneable properties in the pres-
ence of a polymer (polysuccinimide, PSI) and a small-molecule drug
as well.
This work incorporates both physical (Dynamic Light Scattering,
Scanning Electron Microscopy) and mechanical characterization of the
meshes but also the antibacterial effect of AgNPs on four different bacte-
rial strains (E. coli, P. aeruginosa, B. subtilis, S. epidermidis) as well as the
drug-release profile of the paracetamol and finally a method was pro-
posed to compare the antibacterial effect of meshes with different
composition.
2. Materials and methods
2.1. Materials
L-aspartic acid (reagent grade, ≥98%, Amresco), ortophosporic acid
(≥99%, Sigma Aldrich), N,N-dimethylformamide (DMF, anhydrous,
≥ 99.94%, Reanal), chromosulfuric acid (Sigma-Aldrich), silver-
perchlorate (AgClO4, Sigma-Aldrich), paracetamol (APAP, puriss,
98,0%, Alfa Aesar), phospate buffered saline tablet (PBS, Sigma-
Aldrich), Mueller-Hinton agar (Biolab Zrt.), E. coli ATCC 25922,
S. epidermidis ATCC 14990, P. aeruginosa ATCC 27853, B. subtilis ATCC
6633.
All reagents and solvents were used without further purification.
2.2. Synthesis of polysuccinimide
Polysuccinimide (PSI)was prepared by thermal polycondensation of
L-aspartic acid in the presence of orthophosphoric acid. According to a
previously reported method [31], L-aspartic acid and orthophosphoric
acid weremixed at a 1:1weight ratio in a rotating flask and themixture
was gradually heated up to 180 °C while the pressure was gradually re-
duced to 3 mbar using a rotary evaporator. The flask was constantly ro-
tated at 130 rpm for 8 h. The resulting polymer was subsequently
dissolved in 170ml dimethylformamide, then precipitated in deionized
water andwashed several times until a neutral pHwas reached. Finally,
the resulted PSI powder was dried at 40 °C until changes in mass were
not detectable. The polymer was stored in close containers at room
temperature.
2.3. Synthesis of silver nanoparticles
For the synthesis of silver nanoparticles, a one-pot method was de-
veloped based on a previously reported synthesis method [32]. First,
1 g of PSI was dissolved in 4 g of DMF to reach a polymer-
concentration of 20 w/w%. When the dissolution was complete, the so-
lution was saturated with argon after which 0.1 g of AgClO4 was added
to the mixture under the established inert atmosphere. Four different
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Table 1 summarizes the parameters of the prepared samples. In all
cases, reaction mixtures were kept in closed vessels under an inert
atmosphere and stirred for 72 h at 300 rpm and 60 °C (Radleys reactor,
IKA RCT Basic magnetic stirrer).
Sampleswere always stored under an inert atmosphere until further
processing.
Important to mention is that, before every synthesis, every glass-
ware was cleaned using concentrated chromosulfuric acid and
thoroughly washed with ultrapure water (Conductivity <0.1 μS/cm)
to avoid cross-contamination.2.4. Dynamic Light Scattering
After the 72-hour reaction time, the size and polydispersity of the
silver nanoparticles within the PSI/DMF dispersion was evaluated
using a Malvern Nanosizer S instrument equipped with a 4 mW
He-Ne laser (λ = 632,8 nm). Samples were diluted with pure DMF.
The performed dilution was proportionate to the paracetamol con-
tent. In each case, samples were diluted to optimize the count rate
and the gyration coefficient. Approximately 200 μl of the diluted
sample was poured into a disposable cuvette suitable for organic sol-
vents. Details of the measurements were the following: 3 measure-
ments; the number of runs: 15 (each 15 s); backscattering method;
temperature: 25 °C. A general-purpose analysis model was utilized
for data processing then the Stokes-Einstein equation was used for
the calculation of size.2.5. Electrospinning
For the fabrication of silver-nanoparticle (AgNP) containing PSI
meshes (denoted as AgNP/PSI) and for the fabrication of meshes con-
taining both silver-nanoparticle and paracetamol (denoted as AgNP/
APAP/PSI) a two-needle electrospinning setup was used. The setup
comprised of two 5 ml Luer-slip syringes (Chirana, Slovakia) with 18G
metal needles (Becton Dickinson, USA), two single-syringe infusion
pumps (KDS100, KD Scientific, USA) placed opposite to each other on
the two sides of the rotating collector as it is shown on Fig. 1, and high
voltage DC supplies (73030P series, Genvolt, UK) and a slowly rotating
cylindrical collector (RPM = 50, d = 12 cm).
The silver nanoparticle and polymer containing dispersions were
transferred to syringes to which metal needles were attached. Loaded
syringes were then secured to the infusion pumps. Positive electrodes
were attached to the tips of the metal needles while the negative elec-
trodes were clamped to the rotating collector. The electric potential
was provided by the high voltage DC supplies.
Meshes were fabricated within a week after the synthesis at room
temperature (T = 25 ± 2 °C) and at relatively low humidity (Humid-
ity = 22 ± 3%). The electrospinning parameters of all the fabricated
samples are summarized in Table 2.Table 1
Parameters of reaction mixtures.
cAgClO4
(g/5 g 20 w/w% PSI solution)
cparacetamol






In the Results and discussion section, cparacetamol is always given as
paracetamol content mg/5 g where 5 g always refers to the amount of
20 w/w% PSI/DMF polymer solution.
In the case of the sample designated as 0+10, 10mgof paracetamol
was added to a batch of 0mg paracetamol/5 g polymer solution after the
72-hour reaction and right before electrospinning to yield a physical
mixture. After the addition of paracetamol, these samples were stirred
for only 15 min at room temperature to achieve a homogeneous distri-
bution in the highly viscous colloidal system.
2.6. Scanning Electron Microscopy
To investigate the microstructure of the meshes, Scanning Electron
Microscopy was utilized. Images were taken with a JSM 6380LA scan-
ning electron microscope (JEOL, Japan). Samples were secured on an
adaptor with double-sided carbon tape and then coated with a thin
layer of gold using a JFC-1200 Sputter Coating System (JEOL, Japan) to
ensure the required conductivity for the measurement. The applied
voltage was 15 kV and the working distance was 10 cm. Pictures were
obtained at a 1000×, 5000×and 10,000×magnification. Fibre diameters
were determined using Fiji ImageJ software from at least 50 fibres and a
non-parametric one-way ANOVA analysis (Kruskal-Wallis test) was
performed on fibre diameter values to decide which samples have sig-
nificantly different diameter (p < 0.05). Statistical evaluation was per-
formed using STATISTICA 10 software.
2.7. Mechanical testing
The loading capacity of the meshes was evaluated with an Instron
4952 unidirectional mechanical tester (50 N measuring cell). As sum-
marized in Table 2. six different meshes were fabricated and examined.
1.5 × 6 cm test specimens (N=5)were cut fromeach electrospunmesh
parallel to the rotation of the collector as indicated in Fig. 2/a. Samples
were placed between the grips of Instron mechanical tester symmetri-
cally on both ends (Fig. 2/b). Measurements were performed at a
1 mm/min pulling speed until the complete tear of test specimens.
The exact size and mass of the test specimens were measured and
recorded.
The specific maximum load was attained by dividing the maximum
sustained load from the recorded force-deformation curve by the sur-
face mass density (mass/area) to obtain specific maximum load:




¼ Maximum load Nð Þ
mass gð Þ
Area m2ð Þ
A non-parametric one-way ANOVA analysis (Kruskal-Wallis test)
was performed on specific maximum load values to determinewhether
samples significantly differ from each other (p< 0.05). Statistical evalu-







60 300 72 –
60 300 72 Before AgClO4
60 300 72 Before AgClO4
60 300 72 Before AgClO4
Fig. 1. Two-needle electrospinning setup for the fabrication of nanofibrous meshes.
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Antibacterial activity was evaluated using the standardized Kirby-
Bauer disc diffusion method. Four ATCC (American Type Culture Collec-
tion) bacterial strains were used, namely: E. coli (Gram-negative),
P. aeruginosa (Gram-negative), B. subtilis (Gram-positive) and
S. epidermidis (Gram-positive).
Bacteria colonies from each strain were immersed individually into
5 ml of saline and then the suspensions were diluted to reach a 0.5
McFairland turbidity using a DEN-1 Benchtop Densitomer (Grant In-
struments). A sterile swab was then immersed into the bacteria-
containing saline after which the Muller-Hinton agar was covered
with the bacteria containing solution using the swab.
Before the antibacterial evaluation, membrane discs with a diameter
of 6 mm were cut from the meshes (n = 3 per mesh and per bacteria
strain) and the mass of each disc was measured and recorded. Discs
were sterilized at 120 °C for 2 h using a dry heat sterilizer. These sterile
discswere placed onto the top of the inoculatedMuller-Hinton agar and
then the plateswere incubated for 24 h at 37 °C. After 24 h, the diameter
of the bacteria-free zone (diffusion zone) was measured for each disc.
This evaluation aimed to determine the effect of paracetamol con-
tent on the antibacterial properties of silver nanoparticles. Therefore,
to evaluate the effect of the silver nanoparticles within the meshes,
the antibacterial areas around the test discswere calculated and divided














Drug-release kinetics of cparacetamol = 10 mg/5 g PSI solution and
cparacetamol = 5 mg/5 g PSI solution meshes were examined with an
Agilent 8453 UV-VIS Spectrophotometer. Samples of approximately







(g/5 g PSI solution)
cparacetamol
(mg/5 g PSI solution)
PSI 20 0 0
AgNP/PSI 20 0.1 0
AgNP/APAP/PSI 20 0.1 5




14 kDa). The dialyzing membranes containing the examined meshes
were closed tightly on both ends and immersed into 15 ml of
phosphate-buffered saline (PBS, I = 0.15 M, pH= 7.4) in a glass vessel.
Release media were kept at 37 °C while constantly stirred with mag-
netic bars. At predetermined time intervals, 2 ml of the media was re-
moved and the absorbance values were measured. The removed
volume was replaced with fresh PBS and it was followed for 1 week.3. Results and discussion
3.1. Synthesis of silver nanoparticle in the presence of PSI
Silver nanoparticles were synthesized via a one-pot method based
on the reaction of silver salt and DMF. The schematic representation of
the whole synthesis procedure can be seen in Fig. 3.
This reaction has been well-documented for years now, however,
the addition of a stabilizing agent is required as DMF itself couldn't sta-
bilize the formednanoparticles.Without a stabilizing agent, aggregation
takes place immediately in the solution followed by precipitationwhich
results in macroscopic silver or in simple terms a silver-mirror (a thin
silver layer on the side of the glass synthesis chamber). This phenome-
nonwas also observed in our systemwhere silver-perchlorate and DMF
were mixed for 72 h at 60 °C. Silver precipitation was noticeably visible
on magnetic bars and the glassware.
On the contrary, in the presence of polysuccinimide (PSI), instead of
silver-precipitation, a clearly visible colour change was observed.
While the solution initially is transparent yellow (typical colour of a
PSI/DMF solution) it turns to dark brownduring the synthesis. The pres-
ence of paracetamol next to PSI during the reaction results in a dark dun
colour, different from the colour of the mixture without paracetamol
(sleek dark brown – characteristic of stable colloidal sols). This differ-
ence between the samples wasmost noticeable for the highest paracet-
amol content (50 mg/5 g polymer solution) (Fig. 4). The colour-change
upon increasing paracetamol content is an indirect proof for the grow-
ing particle size of the colloidal system. To prove this prediction, DLS
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Fig. 2. Sample preparation for mechanical testing: a) box represent test specimen cut from electrospunmesh (arrow indicates rotating direction of cylindrical collector), b) test specimen
under load.
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0.1 g silver in 5 g 20 w/w% PSI (without the addition of paracetamol),
these colloidal systems retain their aggregative stability for more than
1month. During 6weeks no precipitationwas observed, evidently indi-
cating that PSI can prevent the aggregation and successfully stabilize the
formed nanoparticles within this period of time.Fig. 3. Schematic representation of PSI synthesis an
5
To examine the contribution of paracetamol to this stabilizing effect,
reaction mixtures without PSI were also prepared. In this case, silver
precipitation was observed on the magnetic bar and on the glass vessel
indicating that paracetamol may have a contribution to the stabilization
but in itself is not effective enough to prevent precipitation (Fig. S1, Sup-
plementary Information).d the following silver-nanoparticle synthesis.
Fig. 4. Colour of the synthesis mixtures: a) PSI/DMF solution b) PSI/DMF and 0.1 g AgClO4 reaction mixture after 72 h c) PSI/DMF, 0.1 g AgClO4 and 50 mg paracetamol after 72 h.
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Antibacterial properties of silver nanoparticles are known to be
strongly dependent on the size of the particles therefore size-
determination is a key aspect in designing effective silver
nanoparticle-containing matrices. For a thorough characterization, the
mean size of the silver nanoparticleswas calculated not just based on in-
tensity, but the size and volumedistribution aswell. The latter twowere
calculated from intensity distribution using Rayleigh (d < λlaser/10) or
Mie-theory (d > λlaser/10) [33].
Three different weighting methods and four parameters (z-average
and intensity-mean, number-mean, volume-mean) can be utilized to
gain more precise and comprehensive information about the colloidal
system in question. One of the most important and most frequently re-
ported parameters of a colloidal system is Z-average which is an
intensity-based attribute determined by a fit to the correlation function.
Along with intensity-mean, these two parameters represent the mean
size of the nanoparticles that contributes most to the overall scattering
thus weighting bigger particles more heavily. On the contrary,
number-mean derives from the number of particles without taking
into consideration particle size, therefore particles of different sizes
are counted having equal numerical value. Therefore, z-average,
intensity-mean, and volume-mean are rather sensitive to the presence
of aggregates while the number-mean can be used to demonstrate the
individual (not aggregated) smaller particles of the system. These four
parameters alongside with polydispersity index (PDI) of the colloidal
system in question are shown in Fig. 5.Fig. 5. Effect of paracetamol on properties of silver nanoparticles a) polydispersity in
6
By plotting the polydispersity index (PDI) as a function of the paracet-
amol content (Fig. 5/a), it can be concluded that paracetamol can reduce
the value of PDI from 0.3 to below 0.1 indicating that increasing amount
of paracetamol facilitates the formation of a highly monodisperse colloi-
dal system. Compared to the PDI, Z-average (Fig. 5/a), namely the overall
average size of the colloidal system, demonstrates anopposingbehaviour:
initially due to the small amount of paracetamol content the z-average
size decreases then as the paracetamol content increases, nanoparticle
size increases accordingly. This behaviour and the size of the nanoparti-
cles are rather perplexing to interpret and it requires not only z-average
but intensity-, number- and volume-mean as well (Fig. 5/b). The cause
of the initial decrease is probably due to paracetamol being able to hinder
the aggregation of the nanoparticles in a more effective manner than PSI
in itself does. While PSI can prevent the precipitation of silver nanoparti-
cles, it also can not entirely impede particle aggregation indicated by the
initial gap between number-mean size and intensity-mean size. The
higher value of intensity-mean size (and z-average) suggests the pres-
ence of aggregates while the low value of number-mean size demon-
strates that the majority of the particles still have an average size of
37 nm. Upon addition of paracetamol, even in a small concentration
(5 mg/5 g PSI solution), intensity-, volume- and number-mean values
start to approximate each other which implies that an increase in the
paracetamol content results in a more well-defined, larger sized but
monodisperse colloidal system with narrow size deviations.
To further visualize the effect of paracetamol on the properties of
this complex colloidal system, intensity distributions were compared
to each other (Fig. 5/c). The intensity-distribution comparison is quitedex (PDI) and z-average b) particle size and c) intensity-based size distribution.
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content results in a narrower size distribution and a higher maximum
value indicating that paracetamol facilitates the formation of a highly
monodisperse colloidal system.
The results are quite promising since they evidently indicate that PSI
in itself can promote the synthesis of a colloidal systemwith a PDI value
no greater than 0.3. Furthermore, by adjusting the quantity of paraceta-
mol the parameters of this silver colloidal system can be altered in ac-
cordance with the desired properties. Additionally, the synthesis
method seemed to have a satisfying reproducibility (Fig. S2, Supple-
mentary Information).
3.3. Electrospinning
Due to the fact that the reaction mixture doesn't require further pu-
rification or processing, electrospinning could be performed right after
the 72-hour reaction. Noteworthy mentioning is that, while simple,
PSI-only meshes are white, AgNP/PSI and AgNP/APAP/PSI meshes are
bright yellows. In some cases, instead of bright yellow colour, a pale
beige – white colour was observed (Fig. 6). In these cases, the reaction
mixture was analysed with DLS in terms of PDI and particle-size to ex-
amine the possible cause of this pale colour. These DLS data showed a
rather high polydispersity and noisy raw correlation data (Fig. S3, Sup-
plementary Information) implying that the reduction of silver ions and
the consecutive nanoparticle-formationwasn't complete. Therefore, the
vibrant yellow colour seems to be a fast, simple, and reliable indicator of
the mesh and colloid system quality.
Meshes prepared from 50 mg/5 g paracetamol had a slightly darker
colour, but every mesh had the characteristic vibrant yellow colour. No
differences could be observed in texture or manageability nor between
samples containing different amount of paracetamol, nor between pure
PSI and nanoparticle-containing meshes.
Additionally, X-ray Diffraction studies were performed in order to
determine the crystallinity of silver nanoparticles and the physical
form of the encapsulated paracetamol within the meshes. Further de-
tails about the measurements could be found in Supplementary Infor-
mation. Briefly, the results suggest that the presence of paracetamol
enhances the formation of crystalline silver-nanoparticles instead of
amorphous form while crystalline paracetamol couldn't be detected in
the examined sample (Fig. S4, Supplementary Information)
3.4. Fibre morphology and size distribution assessment by Scanning Elec-
tron Microscopy
Scanning Electron Microscopy images confirm that the electro-
spinning method was successfully optimized for every sample. AllFig. 6. a) PSI mesh b) characteristic yellow colour of AgNP/APAP/PSI mesh with go
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samples have a homogenous, randomly orientated fibrous structure
without beads or other artefacts (Fig. 7).
By applying higher magnification, the surface of the fibres can be
evaluated more precisely. Fig. 7 shows a higher magnification only of
a mesh prepared from 0 mg/5 g paracetamol reaction mixture, of
which microstructure is representative and similar to those of the
other meshes as well. Higher magnification depicts a randomly orien-
tated structure and a particularly smooth surface without observable
clots or beads.
Based on fibre analysis, average fibre diameters were calculated for
each type of mesh (Table 3). The average diameter seems to increase
in accordance with increasing paracetamol content in case of samples
where paracetamol was present during the 72-hour reaction (5, 10,
and 50 mg/5 g paracetamol). In case of meshes prepared from
0 + 10 mg/5 g paracetamol mixtures (where paracetamol was added
to the 0 mg/5 g mixture right before electrospinning to yield a physical
mixture), the diameter is approximately the same as in case of 0mg/5 g.
To examine whether paracetamol content and/or particle size in the
colloidal state have a significant effect on the fibre diameter statistical
analysis was performed on fibre diameter values. The statistical results
suggest that fibre diameters significantly differ from each other except
for 0 (without drug) and 0 + 10 (physical mixture) samples which
two samples possess approximately the same average fibre diameter
(results concluded in Table S1, Supplementary Information). This im-
plies that a change in the microstructure occurs upon increasing para-
cetamol content but since 0 + 10 sample has the same diameter as 0
sample, the change is due to an indirect effect of paracetamol and not
solely its presence in the reaction mixture. Fibre diameter increases
with paracetamol content which is following the change of number
mean size of the particles upon growing paracetamol content (Fig. 5/
b). Subsequently, this comparison suggests that increasing paracetamol
content could have an indirect effect on fibre diameter through altering
particle size in the reaction mixture during the 72-hour reaction, and
therefore diameter increases in accordance with the number-mean
size itself. Since in the case of 0 + 10 mg/5 g sample, paracetamol was
only added to the system right before electrospinning, nanoparticle
size was the same as for 0 mg/5 g sample, thus fibre diameters of
these two compositions stay approximately the same.
When comparing particle sizes in colloidal state (Fig. 5) and fibre di-
ameter (Table 3) it is important to know that the size measured by DLS
is not equivalent to particle size inside themesh. Fig. 8 demonstrates the
particle size measured in the colloidal state by DLS and the schematic
hypothesised process of electrospinning at a molecular level. DLS mea-
sures not only the silver-nanoparticle but also the paracetamol and/or
PSI layers being adsorbed to the silver-core. During electrospinning,
the polymer chains and silver nanoparticles are aligned and rearrangedod quality DLS results c) AgNP/APAP/PSI mesh with poor quality DLS results.
Fig. 7. SEM micrographs of AgNP/PSI and AgNP/APAP/PSI composite meshes.
Table 3
Average fibre diameter of electrospun meshes.
Cparacetamol (mg/5 g) Fibre diameter (nm)
0 210 ± 40
0 + 10 210 ± 55
5 240 ± 40
10 275 ± 75
50 325 ± 50
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colloidal state is not equivalent to the particle size within the fibres but
proportional to it.
Since the nanoparticle cores are smaller than the measured size in
the colloidal state, nanoparticles can easily fit inside the fibres without
creating any visible deformations on the surface. Furthermore, the par-
ticle aggregates present in the 0 and 0 + 10 samples (indicated by in-
tensity mean on Fig. 5/b do not influence the size of the fibres sinceFig. 8. a) schematic representation of particle size measured in colloida
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their quantity is overweighed by smaller particles (indicated by number
mean). To conclude, particle size is a key parameter which has a signif-
icant influence on the fibre diameter.
3.5. Mechanical testing and the effect of fibre diameter
To evaluate the effect of paracetamol on themechanical parameters,
tensile measurements were performed. Individual tensile curves of the
meshes were very similar for every test specimen (PSI and AgNP-
containing meshes with different drug concentrations as well) as it is
shown in Fig. S5, Supplementary Information. The maximum value of
the curves (maximum load) however is highly dependent on the thick-
ness of the test specimen therefore maximum load in itself is not a
proper value to compare the capacity of meshes of different composi-
tions. For this purpose, a specific maximum loadwas calculated. The re-
sults are concluded in Fig. 9.
Since results vary in a narrow range (between 0.15 and 0.18 N*m2/g
for specific maximum value in case of paracetamol containing samples),l state b) particle and fibre rearrangement during electrospinning.
Fig. 9. Specific maximum load as a function of paracetamol content; * indicates significant
difference (p < 0.05) between samples.
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whether paracetamol induces a significant change in the examinedprop-
erty. Therefore, statistical analysis (Kruskal-Wallis test) was performed
on specific maximum values as well (Table S2, Supplementary Informa-
tion). Results (Fig. 9) indicate that PSI and 0mg paracetamol/5 g samples
have a significantly different mechanical capacity from every
paracetamol-containing sample and from each other as well, while all
paracetamol-containing samples exhibit statistically similar mechanical
properties compared to each other. Based on these results, silver nano-
particles do indeed increase the specific maximum load of the meshes
when compared to pure PSI membranes and interestingly the addition
of paracetamol seems to further strengthen the membranes.
The underlying mechanism of the reinforcing effect of paracetamol
acts on two fronts. Firstly, according to the result of fibre analysis, the
presence of paracetamol in the reaction mixture alters the fibre diame-
ter of electrospun meshes (as it was presented in the previous chapter
Table 3) which can alter themechanical properties [34]. Secondly, para-
cetamol may induce mild secondary bonds between polymer chains
resulting in increased mechanical capacities.
To investigate the aforementioned reinforcingmechanisms,first, the
correlation between fibre diameter and specific maximum load was
examined.
Regardingfibre diameter, the increasingparacetamol content results
in an increasing mean value except in the samples denoted as
0 + 10 mg/5 g paracetamol (Table 3). Opposingly - according to statis-
tical analysis - the specific maximum load doesn't increase upon
increasing amount of paracetamol. Specificmaximum loads are approx-
imately the same in case of every paracetamol-containing sample
independently from the measured fibre diameter.
While fibre diameter is in correlation with the size of the nanoparti-
cles, therefore, depends indirectly on paracetamol content, the specific
maximum load seems to be independent on the paracetamol content
in the range of 5–50 mg paracetamol/5 g: when paracetamol is present
in even a small quantity (5 mg/5 g), specific maximum load increases.
According to the results, the specificmaximum load is also independent
on themoment of paracetamol-addition (after or before the 72-hour re-
action), since even in case of sample 0 + 10 mg/5 g specific maximum
load is elevated compared to meshes without paracetamol.
This indicates that paracetamol doesn't alter maximum mechanical
capacity through changing particle size and consequently fibre diame-
ter, but rather through inducing weak secondary bonds.9
3.6. Antibacterial properties
Silver nanoparticles are known to be effective against both Gram-
positive and Gram-negative bacteria strains, however, their antibacte-
rial spectra and properties are highly dependent on their silver-ion re-
leasing capacity which could be hindered by the macroscopic carrier
itself or even by a small-molecule drug. To evaluate whether paraceta-
mol and/or PSI hinder or enhance the antibacterial properties of silver
nanoparticles four bacteria strains were utilized. S. epidermidis and
P. aeruginosa pose a high risk of wound healing as they are easily ac-
quired and hard to eradicate with antibiotics. B. subtilis and E. coli on
the other hand are frequently utilized Gram-positive and Gram-
negative model strains.
PSI in itself did not prove to be effective against bacteria strains,
although in some cases slightly visible, narrow clear zones around the
meshes could be observed (Fig. 10/a), which might be due to PSI alter-
ing the pH locally due to its hydrolyzation [24]. The antibacterial effect
of silver nanoparticles derives from silver-ion being released from the
surface of nanoparticles. The efficacy against bacteria and other micro-
organisms is therefore dependent on the surface area: smaller nanopar-
ticles release higher concentration of silver-ions rendering them more
effective against bacteria strains [35]. Accordingly it is paramount to
examine the effect of particle size on the antibacterial properties.
In addition, apart from the size of particles, shape [15] and – in our
case more importantly - surface coverage also influences their antibac-
terial properties [36,37]. Consequently, the effect of paracetamol con-
tent can't be neglected, since increasing paracetamol content can
decrease the free surface area of silver nanoparticles by increasing
surface coverage. In other words, paracetamol content can have a direct
effect on the antibacterial efficacy. Therefore, to visualize the effect of
paracetamol on the antibacterial properties of silver nanoparticles
themselves, specific antibacterial area (diffusion zone divided by silver
content) was plotted as the function of composition (Fig. 10/b).
As it is indicated by the photos - showing themost and least effective
compositions (Fig. 10/c and d) - and the calculated specific antibacterial
area values, paracetamol content changes the antibacterial efficacy of
the silver nanoparticles both in case of Gram-positive and Gram-
negative bacterial strains. The antibacterial efficacy as a function of
paracetamol content has a maximum value at 5 mg paracetamol/5 g
PSI solution for every bacteria strain. Interestingly S. epidermidis seems
to be more susceptible to the antibacterial effect of the synthesized sys-
tem and in this case, the maximum peak is not as obvious as for the
other three strains. The correlation between paracetamol content and
antibacterial efficacy is not linear, therefore, it is worth to compare the
particle size itself and the specific antibacterial area as well.
Fig. S6 (Supplementary Information) compares the intensity-based
and the number-based particle size of the nanoparticles measured by
DLS and the specific antibacterial area. Although the size measured by
DLS indicates particle size in a colloidal state (Fig. 5/b) (instead of the
actual size inside the mesh), a correlation can be observed between
intensity-based particle size and antibacterial area. In the case of sam-
ples where intensity-based particle size (intensity mean) was large
due to aggregation, the antibacterial property seems to be hindered.
The two most effective samples – 5 and 10 mg paracetamol/5 g – have
the lowest intensity-mean values (5 mg/5 g: 113.6 ± 1.3 nm; 10 mg/
5 g: 119.9 ± 2.1 nm), indicating small particle size and low tendency
for aggregation.
The number-mean size has a less obvious correlation with the anti-
bacterial area, although, in the case of 5, 10 and 50 mg paracetamol/5 g
samples, as the numbermean size increases antibacterial area decreases
(Fig. S6/b, Supplementary Information).
The samples with the highest paracetamol content (50 mg/5 g)
didn't exhibit measurable bacterial inhibition. Since the intensity-
mean size belonging to this highest paracetamol content is smaller
than those of 0 and 0 + 10 samples, the lack of inhibition can be ex-
plained with the surface interaction (chemical or physical adsorption)
Fig. 10. a) Kirby-Bauer or Disc diffusion method using PSI membranes b) Specific antibacterial area of silver nanoparticles within electrospun meshes and diffusion zone of c) the most
effective sample: 5 mg/5 g APAP meshes d) the least effective sample: 50 mg/5 g APAP meshes with all tested bacteria strains.
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the surface of nanoparticles and therefore can affect the release of silver
ions into the surrounding medium [37]. Since upon the addition of
50 mg paracetamol, antibacterial activity is completely hindered, it
can be assumed that paracetamol adheres to the surface of the particles
and hinder silver-ion release. The same reason can cause different spe-
cific antibacterial areas for 0 and 0 + 10 samples. While the size of the
nanoparticles is the same for these two samples and therefore similar
antibacterial effect would be expected, the additional paracetamol
causes a slightly smaller specific antibacterial area for 0 + 10 samples.10These results highlight that the addition of a small molecule drug
such as paracetamol can act in three possible ways: a. hinder the aggre-
gation of nanoparticles which increases the surface area and therefore
the antibacterial efficacy b. the increased amount of paracetamol caused
an increase in the size of the nanoparticles making them less effective
against bacteria c. small molecules can hinder antibacterial effect by de-
creasing the free surface which inhibits the silver ion release.
Results show that designing effective antibacterial nanocomposites
roots in the thorough adjustment and measurement of the colloidal pa-
rameters as they have a great effect on the efficacy of the macroscopic
D. Barczikai, V. Kacsari, J. Domokos et al. Journal of Molecular Liquids 322 (2021) 114575system. The antibacterial properties can be tuned by adjusting the size
of the nanoparticles but also simply by the addition of a small molecule
drug, the antibacterial efficacy could be altered.
3.7. Drug-release kinetics
For drug-release measurements two different compositions were
examined, 5 and 10 mg paracetamol/5 g samples were chosen since
they exhibited the highest antibacterial effect, therefore they hold
promise for future applications. Drug release measurements were per-
formed for 8 days. The kinetics could be divided into three consecutive
steps with different release speed indicated by the slope of curves
(Fig. 11).
In the first 1,5 h, the release occurs in a fast manner. In this period,
being immersed into a physiological buffer, PSI absorbs water and an
8-fold increase in the mass of the meshes can be measured (data not
shown here). Due to this water uptake and the high surface to volume
ratio of the fibres a burst release of the encapsulated drug can occur
(Fig. 11/a, 1st fit) [38]. In the third and second hour a slightly slower re-
lease is observed and the released amount of drug reaches approxi-
mately 40% of the encapsulated content for both composition (Fig. 11/
a, 2nd fit). Subsequently, a slow release begins after 24 h (Fig. 11/b,
3rd fit). At physiological pH, PSI slowly undergoes hydrolysis and
water-soluble poly(aspartic acid) is formed. During this hydrolysis, the
superficial layer of the meshes starts to slowly dissolve, therefore fur-
ther slow release can be observed in the following 6 days. In the case
of 5 mg/5 g sample, there's a sudden increase in the released amount
from 80 to 90% after 168 h. This sudden increase only occurs in the
case of this smallest paracetamol content (but not in case of 10 mg/5 g
paracetamol samples) indicating that increasing the paracetamol con-
tent can increase the hydrolytic stability as well. Mechanical measure-
ments suggested that paracetamol might induce mild secondary
bonds that can strengthen the membranes. These secondary bonds
can have an effect on hydrolytic properties as well: higher paracetamol
content can reduce the swelling capacity of meshes and increase their
hydrolytic stability through the aforementioned mild secondary bonds.
Drug release studies revealed that more than 70% of the encapsu-
lated drug can be released from electrospun PSI-AgNP nanocomposite
meshes depending on the exact composition. For higher paracetamol
content (10 mg/5 g) only 70% of the encapsulated drug was released,
which might indicate the physical or chemical adsorption of paraceta-
mol on the surface of silver-nanoparticles. To investigate the possible
adsorption of paracetamol and reaction between the drug and silver-
nanoparticles, drug-release measurements with 0 + 10 g paraceta-
mol/5 g meshes was performed. Results are presented in Supplemen-
tary Information. Briefly, in case of physical mixture (0 + 10 mg/5 gFig. 11. Release kinetics for chosen
11paracetamol) release occurred in a faster manner (Fig. S7, Supplemen-
tary Information) and based on the performed measurements the
amount of release drug was also higher in case of 0 + 10 g/5 g paracet-
amol meshes. These data indirectly prove that during the 72-h reaction
of silver nanoparticles paracetamol can adsorb chemically or physically
on the surface of the nanoparticles which alters the drug-release profile
of the macroscopic mesh. In case of physical mixtures, a rather sudden
and fast release occurswhichmight be unfavourable for severalmedical
applications. These findings were further proved by HPLC measure-
ments performed on the release media of the aforementioned samples.
The HPLC chromatogramswere compared to those of pure paracetamol.
Further results can be found in Supplementary Information.
4. Conclusion
In this work, we presented a one-pot synthesis method and
electrospinning procedure to synthesize silver-nanoparticles with
tuneable properties and subsequently fabricate polysuccinimide nano-
composite meshes with antibacterial properties. Silver nanoparticle
synthesis was based on the reaction between DMF and silver-salt re-
ported by Pastoriza-Santos et al [32,39]. Here we presented a method
for the synthesis of silver nanoparticles in the presence of paracetamol
and PSI at a high concentration (20 w/w%). This method results in a
highly viscous polymer-nanoparticle colloidal system that is suitable
for electrospinning without any further modification or addition. As it
was indicated by DLS results, AgNP synthesis was successfully per-
formed and PSI, together with paracetamol, facilitates the formation of
a highly monodispersed silver colloidal system of which properties
(size, aggregative stability, PDI) could be tuned by adjusting paraceta-
mol content. A two-needle electrospinning set up proved to be success-
ful for the effective fabrication of silver nanoparticles and paracetamol
containing PSI meshes. The microstructure was observed with SEM for
every composition and a correlation between particle size and fibre di-
ameter was established. Themechanical evaluation indicated that silver
nanoparticles can reinforce pure PSI membranes, and interestingly, the
addition of paracetamol can further enhance the mechanical properties
of the nanocomposite meshes. Antibacterial evaluation suggested that
antibacterial efficacy is a function of the paracetamol content highlight-
ing that the addition of a small molecule can change the antibacterial
properties of nanoparticles which is in accordance with previous find-
ings [36,37]. Release kinetics showed a four-stage drug release. The re-
leased amount of drug (%) was a function of exact composition as
paracetamol seems to alter the hydrolytic stability of the meshes as
well.
Functionalized PSI has been previously used to prepare silver-
nanoparticle containing hydrogels [40], but to our knowledge, this issamples: a) first 3 h, b) 7 days.
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containing multifunctional nanocomposite. Nanoparticle containing fi-
brous meshes have been widely investigated [41] even using similar
synthesis methods [42,43], but a comprehensive investigation both on
a colloidal and macroscopic level and the comparison between nano-
scale and macroscopic properties are rather rare. Additionally, this pro-
posed synthesis and electrospinningmethod could be further combined
with other pharmaceutical agents, moreover PSI fibres can be even
combined with entirely different electrospun polymers without un-
wanted interactions utilizing co-electrospun technique to improve me-
chanical and drug-release properties [44].
CRediT authorship contribution statement
Dóra Barczikai (NP synthesis and characterization, electrospun fibre
formation, SEM investigation, drug release, mechanical measurements,
experiment consultant)
Viktória Kacsari (NP synthesis, drug release)
Judit Domokos (assistance in the antibacterial study)
Dóra Szabó (supervision of the antibacterial study)
Angela Jedlovszky-Hajdu (supervision of the project (original idea),
preparation of the manuscript)
Declaration of competing interest
There are no known conflicts of interest associatedwith this publica-
tion and there has been no financial support for this work that could
have influenced its outcome.
Acknowledgment
This work was supported by the National Research Development
and Innovation Office (NKFIH FK 124147), the János Bolyai Research
Scholarship of the Hungarian Academy of Sciences (JHA) and by the
new national excellence program of the Ministry for Innovation and
Technology (ÚNKP-19-4-SE-04, ÚNKP-20-5-SE-9). The research was fi-
nanced by the Higher Education Institutional Excellence Programme of
the Ministry for Innovation and Technology in Hungary, within the
framework of the Therapeutic Development thematic programme of
the Semmelweis University.
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.molliq.2020.114575.
References
[1] A.C.D.O. Gonzalez, Z.D.A. Andrade, T.F. Costa, A.R.A.P. Medrado, Wound healing - a
literature review, An. Bras. Dermatol. 91 (2016) 614–620, https://doi.org/10.1590/
abd1806-4841.20164741.
[2] A. Oliveira, S. Simões, A. Ascenso, C.P. Reis, Therapeutic advances inwound healing, J
Dermatolog Treat 0 (2020) 000, https://doi.org/10.1080/09546634.2020.1730296.
[3] M.E. Okur, I.D. Karantas, Z. Şenyiğit, N. Üstündağ Okur, P.I. Siafaka, Recent trends on
wound management: new therapeutic choices based on polymeric carriers, Asian J
Pharm Sci (2020)https://doi.org/10.1016/j.ajps.2019.11.008.
[4] S. Dhivya, V.V. Padma, E. Santhini, Wound dressings - a review, Biomed 5 (2015)
24–28, https://doi.org/10.7603/s40681-015-0022-9.
[5] I. Negut, V. Grumezescu, A.M. Grumezescu, Treatment strategies for infected
wounds, Molecules 23 (2018) 1–23, https://doi.org/10.3390/molecules23092392.
[6] U.H. Abo-Shama, H. El-Gendy, W.S. Mousa, R.A. Hamouda, W.E. Yousuf, H.F. Hetta,
et al., Synergistic and antagonistic effects of metal nanoparticles in combination
with antibiotics against some reference strains of pathogenic microorganisms, Infect
Drug Resist 13 (2020) 351–362, https://doi.org/10.2147/IDR.S234425.
[7] J.O.D. Malafatti, M.P. Bernardo, F.K.V. Moreira, H. Ciol, N.M. Inada, L.H.C. Mattoso,
et al., Electrospun poly(lactic acid) nanofibers loaded with silver sulfadiazine/
[Mg–Al]-layered double hydroxide as an antimicrobial wound dressing, Polym.
Adv. Technol. (2020) 1377–1387, https://doi.org/10.1002/pat.4867.
[8] K. Vowden, P. Vowden, Wound dressings: principles and practice, Surg (United
Kingdom) 35 (2017) 489–494, https://doi.org/10.1016/j.mpsur.2017.06.005.12[9] K. Ousey, K.F. Cutting, A.A. Rogers, M.G. Rippon, The importance of hydration in
wound healing: reinvigorating the clinical perspective, J. Wound Care 25 (2016)
122–130, https://doi.org/10.12968/jowc.2016.25.3.122.
[10] W.F. Oliveira, P.M.S. Silva, R.C.S. Silva, G.M.M. Silva, G. Machado, L.C.B.B. Coelho,
et al., Staphylococcus aureus and Staphylococcus epidermidis infections on im-
plants, J Hosp Infect 98 (2018) 111–117, https://doi.org/10.1016/j.jhin.2017.11.008.
[11] J. Stewart, A short note on the nutritive value of linseed cake, J. Agric. Sci. 18 (1928)
702–703, https://doi.org/10.1017/S0021859600009278.
[12] L. Wang, C. Hu, L. Shao, The antimicrobial activity of nanoparticles: present situation
and prospects for the future, Int. J. Nanomedicine 12 (2017) 1227–1249, https://doi.
org/10.2147/IJN.S121956.
[13] Z. Pang, R. Raudonis, B.R. Glick, T.J. Lin, Z. Cheng, Antibiotic resistance in Pseudomo-
nas aeruginosa: mechanisms and alternative therapeutic strategies, Biotechnol. Adv.
37 (2019) 177–192, https://doi.org/10.1016/j.biotechadv.2018.11.013.
[14] A. Elbourne, R.J. Crawford, E.P. Ivanova, Nano-structured antimicrobial surfaces:
from nature to synthetic analogues, J. Colloid Interface Sci. 508 (2017) 603–616,
https://doi.org/10.1016/j.jcis.2017.07.021.
[15] N.Y. Lee, W.C. Ko, P.R. Hsueh, Nanoparticles in the treatment of infections caused by
multidrug-resistant organisms, Front. Pharmacol. 10 (2019) 1–10, https://doi.org/
10.3389/fphar.2019.01153.
[16] I. Khansa, A.R. Schoenbrunner, C.T. Kraft, J.E. Janis, Silver in wound care - friend or
foe?: a comprehensive review, Plast Reconstr Surg - Glob Open 7 (2019) 1–10,
https://doi.org/10.1097/GOX.0000000000002390.
[17] S.M. Dizaj, F. Lotfipour, M. Barzegar-Jalali, M.H. Zarrintan, K. Adibkia, Antimicrobial
activity of the metals and metal oxide nanoparticles, Mater Sci Eng C 44 (2014)
278–284, https://doi.org/10.1016/j.msec.2014.08.031.
[18] E. Zdraveva, J. Fang, B. Mijovic, T. Lin, Electrospun Nanofibers, 2016https://doi.org/
10.1016/B978-0-08-100550-7.00011-5.
[19] R. Rošic, P. Kocbek, J. Pelipenko, J. Kristl, S. Baumgartner, Nanofibers and their bio-
medical use, Acta Pharma. 63 (2013) 295–304, https://doi.org/10.2478/acph-
2013-0024.
[20] I. Sebe, E. Ostorhazi, A. Fekete, K.N. Kovacs, R. Zelko, I. Kovalszky, et al., Polyvinyl al-
cohol nanofiber formulation of the designer antimicrobial peptide APO sterilizes
Acinetobacter baumannii-infected skin wounds in mice, Amino Acids 48 (2016)
203–211, https://doi.org/10.1007/s00726-015-2080-4.
[21] A.R. Unnithan, N.a.M. Barakat, P.B. Tirupathi Pichiah, G. Gnanasekaran, R. Nirmala,
Y.S. Cha, et al., Wound-dressing materials with antibacterial activity from
electrospun polyurethane-dextran nanofiber mats containing ciprofloxacin HCl,
Carbohydr. Polym. 90 (2012) 1786–1793, https://doi.org/10.1016/j.carbpol.2012.
07.071.
[22] H. Maleki, S. Mathur, A. Klein, Antibacterial Ag containing core-shell polyvinyl
alcohol-poly (lactic acid) nanofibers for biomedical applications, Polym. Eng. Sci.
(2020) 1–10, https://doi.org/10.1002/pen.25375.
[23] P. Zahedi, I. Rezaeian, S.O. Ranaei-Siadat, S.H. Jafari, P. Supaphol, A review on wound
dressingswith an emphasis on electrospun nanofibrous polymeric bandages, Polym.
Adv. Technol. 21 (2010) 77–95, https://doi.org/10.1002/pat.1625.
[24] E. Krisch, B. Gyarmati, D. Barczikai, V. Lapeyre, B.Á. Szilágyi, V. Ravaine, et al., Poly
(aspartic acid) hydrogels showing reversible volume change upon redox stimulus,
Eur. Polym. J. 105 (2018) 459–468, https://doi.org/10.1016/j.eurpolymj.2018.06.
011.
[25] K. Molnar, A. Jedlovszky-Hajdu, M. Zrinyi, S. Jiang, S. Agarwal, Poly(amino acid)-
based gel fibers with pH responsivity by coaxial reactive electrospinning, Macromol.
Rapid Commun. 38 (2017) 1–5, https://doi.org/10.1002/marc.201700147.
[26] P. Ferruti, S. Manzoni, S.C.W. Richardson, R. Duncan, N.G. Pattrick, R. Mendichi, et al.,
Amphoteric linear poly(amido-amine)s äs endosomolytic polymers: correlation be-
tween physicochemical and biological properties, Macromolecules 33 (2000)
7793–7800, https://doi.org/10.1021/ma000378h.
[27] S. Km, J.-H. Kim, D. Kim, pH sensitive swelling and releasing behavior of nano-gels
based on polyaspartamide graft copolymers, J. Colloid Interface Sci. 356 (2011)
100–106.
[28] J. Liu, C. Jin, C. Wang, Hyperbranched thiourea-grafted electrospun polyacrylonitrile
fibers for efficient and selective gold recovery, J. Colloid Interface Sci. 561 (2020)
449–458.
[29] G. Piccirillo, B. Bochicchio, A. Pepe, K. Schenke-Layland, S. Hinderer, Electrospun
poly-L-lactide scaffold for the controlled and targeted delivery of a synthetically ob-
tained diclofenac prodrug to treat actinic keratosis, Acta Biomater. 52 (2017)
187–196.
[30] S. Homaeigohar, A.R. Boccaccini, Antibacterial biohybrid nanofibers for wound
dressings, Acta Biomater. 107 (2020) 25–49, https://doi.org/10.1016/j.actbio.2020.
02.022.
[31] K. Molnar, D. Juriga, P.M. Nagy, K. Sinko, A. Jedlovszky-Hajdu, M. Zrinyi, Electrospun
poly(aspartic acid) gel scaffolds for artificial extracellular matrix, Polym. Int. 63
(2014) 1608–1615, https://doi.org/10.1002/pi.4720.
[32] I. Pastoriza-Santos, L.M. Liz-Marzán, Formation of PVP-protected metal nanoparti-
cles in DMF, Langmuir 18 (2002) 2888–2894, https://doi.org/10.1021/la015578g.
[33] S. Bhattacharjee, Review article DLS and zeta potential – what they are and what
they are not? J. Control. Release 235 (2016) 337–351, https://doi.org/10.1016/j.
jconrel.2016.06.017.
[34] A. Baji, Y.-W. Mai, S.-C. Wong, Effect of fiber size on structural and tensile properties
of electrospun polyvinylidene fluoride fibers, Polym. Eng. Sci. 2 (2015)https://doi.
org/10.1002/pen.
[35] Y. Qing, L. Cheng, R. Li, G. Liu, Y. Zhang, X. Tang, et al., Potential antibacterial mech-
anism of silver nanoparticles and the optimization of orthopedic implants by ad-
vanced modification technologies, Int. J. Nanomedicine 13 (2018) 3311–3327,
https://doi.org/10.2147/IJN.S165125.
D. Barczikai, V. Kacsari, J. Domokos et al. Journal of Molecular Liquids 322 (2021) 114575[36] Jingyu, David A. Sonshine, R.H.H. Saira Shervani, Controlled release of biologically
active silver from nanosilver surfaces, ACS Nano 4 (2010) 6903–6913, https://doi.
org/10.1021/nn102272n.
[37] Y.M. Long, L.G. Hu, X.T. Yan, X.C. Zhao, Q.F. Zhou, Y. Cai, et al., Surface ligand controls
silver ion release of nanosilver and its antibacterial activity against Escherichia coli,
Int. J. Nanomedicine 12 (2017) 3193–3206, https://doi.org/10.2147/IJN.S132327.
[38] Y.J. Son, W.J. Kim, H.S. Yoo, Therapeutic applications of electrospun nanofibers for
drug delivery systems, Arch. Pharm. Res. 37 (2014) 69–78, https://doi.org/10.
1007/s12272-013-0284-2.
[39] I. Pastorizo-Santos, L.M. Liz-Marzán, N,N-dimethylformamide as a reaction medium
for metal nanoparticle synthesis, Adv. Funct. Mater. 19 (2009) 679–688, https://doi.
org/10.1002/adfm.200801566.
[40] M. Tan, Y. Choi, J. Kim, J.H. Kim, K.M. Fromm, Polyaspartamide functionalized
catechol-based hydrogels embedded with silver nanoparticles for antimicrobial
properties, Polymers (Basel) 10 (2018)https://doi.org/10.3390/polym10111188.13[41] C.L. Zhang, S.H. Yu, Nanoparticles meet electrospinning: recent advances and future
prospects, Chem. Soc. Rev. 43 (2014) 4423–4448, https://doi.org/10.1039/
c3cs60426h.
[42] H.K. Lee, E.H. Jeong, C.K. Baek, J.H. Youk, One-step preparation of ultrafine poly(ac-
rylonitrile) fibers containing silver nanoparticles, Mater. Lett. 59 (2005)
2977–2980, https://doi.org/10.1016/j.matlet.2005.05.005.
[43] A.K. Selvam, G. Nallathambi, Polyacrylonitrile/silver nanoparticle electrospun nano-
composite matrix for bacterial filtration, Fibers Polym 16 (2015) 1327–1335,
https://doi.org/10.1007/s12221-015-1327-8.
[44] C. Voniatis, L. Balsevicius, D. Barczikai, D. Juriga, A. Takács, L. Kőhidai, et al., Co-
electrospun polysuccinimide/poly(vinyl alcohol) composite meshes for tissue engi-
neering, J. Mol. Liq. 306 (2020)https://doi.org/10.1016/j.molliq.2020.112895.
